NO20063392L - Indoler, 1H-indazoler, 1,2-benzisoksazoler og 1,2-benzisotiazoler, og fremstilling og anvendelser derav - Google Patents

Indoler, 1H-indazoler, 1,2-benzisoksazoler og 1,2-benzisotiazoler, og fremstilling og anvendelser derav

Info

Publication number: NO20063392L
Authority: NO; Norway
Prior art keywords: benzisoxazoles; benzisothiazoles; indazoles; indoles; compounds
Prior art date: 2003-12-22

Application number

NO20063392A

Other languages

English (en)

Norwegian (no)

Inventor

Ashok Tehim

Richard Schumacher

Brian Herbert

Truc Minh Nguyen

Wenge Xie

Carla-Maria Gauss

Jianguo Ma

Original Assignee

Memory Pharm Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-22

Filing date

2006-07-21

Publication date

2006-09-21

2006-07-21 Application filed by Memory Pharm Corp filed Critical Memory Pharm Corp

2006-09-21 Publication of NO20063392L publication Critical patent/NO20063392L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Cardiology (AREA)
Virology (AREA)
Obesity (AREA)
Psychology (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Physical Education & Sports Medicine (AREA)
AIDS & HIV (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Molecular Biology (AREA)

NO20063392A 2003-12-22 2006-07-21 Indoler, 1H-indazoler, 1,2-benzisoksazoler og 1,2-benzisotiazoler, og fremstilling og anvendelser derav NO20063392L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US53089103P	2003-12-22	2003-12-22
US60689704P	2004-09-03	2004-09-03
PCT/US2004/042852 WO2005063767A2 (en)	2003-12-22	2004-12-22	Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof

Publications (1)

Publication Number	Publication Date
NO20063392L true NO20063392L (no)	2006-09-21

Family

ID=34742980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20063392A NO20063392L (no)	2003-12-22	2006-07-21	Indoler, 1H-indazoler, 1,2-benzisoksazoler og 1,2-benzisotiazoler, og fremstilling og anvendelser derav

Country Status (22)

Country	Link
US (4)	US7396833B2 (pt)
EP (1)	EP1697378B1 (pt)
JP (1)	JP4824578B2 (pt)
KR (1)	KR20060120694A (pt)
AU (1)	AU2004309367B2 (pt)
BR (1)	BRPI0417323A (pt)
CA (1)	CA2550689A1 (pt)
CR (1)	CR8472A (pt)
DE (1)	DE602004010299T2 (pt)
DK (1)	DK1697378T3 (pt)
EC (1)	ECSP066669A (pt)
ES (1)	ES2295973T3 (pt)
IL (1)	IL176283A0 (pt)
MA (1)	MA28228A1 (pt)
NO (1)	NO20063392L (pt)
NZ (1)	NZ548228A (pt)
PL (1)	PL1697378T3 (pt)
PT (1)	PT1697378E (pt)
RS (1)	RS20060391A (pt)
RU (1)	RU2389729C2 (pt)
SG (1)	SG149830A1 (pt)
WO (1)	WO2005063767A2 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004083388A2 (en)	2003-03-14	2004-09-30	Bristol-Myers Squibb Company	Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
JP2007534692A (ja) *	2004-04-22	2007-11-29	メモリー・ファーマシューティカルズ・コーポレイション	インドール、１ｈ−インダゾール、１，２−ベンズイソキサゾール、１，２−ベンゾイソチアゾール、ならびにその調製および使用
US8143254B2 (en) *	2005-02-18	2012-03-27	Cornell Research Foundation, Inc.	Methods for modulating ion channels
JP2009509964A (ja) *	2005-09-23	2009-03-12	メモリー・ファーマシューティカルズ・コーポレイション	インダゾール類、ベンゾチアゾール類、ベンゾイソオキサゾール類、ピラゾロピリジン類、イソチアゾロピリジン類、およびそれらの製造と用途
US8106066B2 (en)	2005-09-23	2012-01-31	Memory Pharmaceuticals Corporation	Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
AU2006311422A1 (en) *	2005-11-09	2007-05-18	Memory Pharmaceuticals Corporation	1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
CA2648168A1 (en) *	2006-04-11	2007-10-18	F. Hoffmann-La Roche Ag	Heterocyclic gaba alpha subtype selective receptor modulators
WO2008005910A2 (en) *	2006-07-06	2008-01-10	Bristol-Myers Squibb Company	Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
TW200840569A (en) *	2007-03-13	2008-10-16	Targacept Inc	Sub-type selective amides of diazabicycloalkanes
ATE545417T1 (de)	2007-03-14	2012-03-15	Ranbaxy Lab Ltd	Pyrazoloä3,4-büpyridin-derivate als phosphodiesterasehemmer
US8697722B2 (en) *	2007-11-02	2014-04-15	Sri International	Nicotinic acetylcholine receptor modulators
EP2346833B1 (en) *	2008-10-13	2013-03-27	F. Hoffmann-La Roche AG	Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides
JO3250B1 (ar)	2009-09-22	2018-09-16	Novartis Ag	إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
KR20120083905A (ko)	2009-10-09	2012-07-26	자프겐 코포레이션	비만의 치료에 사용하기 위한 설폰 화합물
PH12012501068A1 (en) *	2009-12-07	2013-02-04	Targacept Inc	3,6-diazabicyclo [3.1.1] heptanes as neuronal nicotinic acetylcholine receptor ligands
CA2787063C (en)	2010-01-11	2018-11-27	Astraea Therapeutics, Llc	Nicotinic acetylcholine receptor modulators
US20110172428A1 (en)	2010-01-12	2011-07-14	Shan-Ming Kuang	Methods for the preparation of indazole-3-carboxylic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt
US8242276B2 (en)	2010-06-30	2012-08-14	Hoffmann-La Roche Inc.	Methods for the preparation of N-(S)-1-azabicyclo[2.2.2]oct-3-yl-1H-indazole-3-carboxamide hydrochloride salt
CN103249735B (zh)	2010-07-22	2016-04-06	扎夫根股份有限公司	三环化合物及其制备和使用方法
EP2668169B1 (en)	2011-01-26	2017-11-15	Zafgen, Inc.	Tetrazole compounds and methods of making and using same
US9242997B2 (en)	2011-05-06	2016-01-26	Zafgen, Inc.	Tricyclic pyrazole sulphonamide compunds and methods of making and using same
AU2012253759B2 (en)	2011-05-06	2016-01-21	Zafgen Inc.	Tricyclic sulfonamide compounds and methods of making and using same
BR112013028534A2 (pt)	2011-05-06	2016-09-06	Zafgen Inc	compostos tricíclicos parcialmente saturados e métodos para produção e utilização dos mesmos
WO2013092850A1 (en)	2011-12-23	2013-06-27	Basf Se	Process for manufacturing aryloxyacetamides
JP2015509102A (ja)	2012-01-18	2015-03-26	ザフゲン，インコーポレイテッド	三環式スルホン化合物並びにその作製および使用方法
CA2861390A1 (en)	2012-01-18	2013-07-25	Zafgen, Inc.	Tricyclic sulfonamide compounds and methods of making and using same
JP6088491B2 (ja) *	2012-04-10	2017-03-01	大日本住友製薬株式会社	新規１位置換インダゾール誘導体
US8889730B2 (en)	2012-04-10	2014-11-18	Pfizer Inc.	Indole and indazole compounds that activate AMPK
TW201414734A (zh)	2012-07-10	2014-04-16	Takeda Pharmaceutical	氮雜吲哚衍生物
JP6169716B2 (ja)	2012-11-05	2017-07-26	ザフゲン，インコーポレイテッド	肝疾患を治療する方法
BR112015010225A2 (pt)	2012-11-05	2017-07-11	Zafgen Inc	compostos tricíclicos e seus métodos de produção e utilização
BR112015010223A2 (pt)	2012-11-05	2017-07-11	Zafgen Inc	compostos tricíclicos para o uso no tratamento e/ou controle de obesidade
JP6064062B2 (ja)	2013-03-15	2017-01-18	ファイザー・インク	Ａｍｐｋを活性化させるインダゾール化合物
WO2015106012A1 (en)	2014-01-09	2015-07-16	Takeda Pharmaceutical Company Limited	Azaindole derivatives
KR101532211B1 (ko) *	2014-04-30	2015-06-30	세종대학교산학협력단	Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물 및 방법
WO2016054123A1 (en)	2014-09-30	2016-04-07	Lightner Derek	Methods of producing heteropolycycles via bis-epoxidation
DE102015012050A1 (de) *	2015-09-15	2017-03-16	Merck Patent Gmbh	Verbindungen als ASIC-Inhibitoren und deren Verwendungen
CN111892599B (zh) *	2020-08-14	2023-01-13	黄芳	一种2,5-二氮杂双环[2.2.2]辛烷-2-羧酸叔丁酯的合成方法
WO2022125377A1 (en) *	2020-12-08	2022-06-16	Disarm Therapeutics, Inc.	Benzopyrazole inhibitors of sarm1

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL59004A0 (en)	1978-12-30	1980-03-31	Beecham Group Ltd	Substituted benzamides their preparation and pharmaceutical compositions containing them
FI74707C (fi)	1982-06-29	1988-03-10	Sandoz Ag	Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
JPS5936675A (ja)	1982-07-13	1984-02-28	サンド・アクチエンゲゼルシヤフト	二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
FR2548666A1 (fr)	1983-07-08	1985-01-11	Delalande Sa	Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
WO1985001048A1 (en)	1983-08-26	1985-03-14	Sandoz Ag	Aromatic esters or amides of carboxylic acid and sulfonic acid
US4605652A (en)	1985-02-04	1986-08-12	A. H. Robins Company, Inc.	Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
US4937247A (en)	1985-04-27	1990-06-26	Beecham Group P.L.C.	1-acyl indazoles
DE3650772T2 (de)	1985-04-27	2003-04-03	F. Hoffmann-La Roche Ag, Basel	Derivate von Indazole-3-carboxamide und -3-carboxylsäure
GB8623142D0 (en)	1986-09-26	1986-10-29	Beecham Group Plc	Compounds
GB8518658D0 (en)	1985-07-24	1985-08-29	Glaxo Group Ltd	Medicaments
US5204356A (en)	1985-07-24	1993-04-20	Glaxo Group Limited	Treatment of anxiety
GB8520616D0 (en)	1985-08-16	1985-09-25	Beecham Group Plc	Compounds
IN166416B (pt)	1985-09-18	1990-05-05	Pfizer
US4910193A (en)	1985-12-16	1990-03-20	Sandoz Ltd.	Treatment of gastrointestinal disorders
HU202108B (en)	1986-07-30	1991-02-28	Sandoz Ag	Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
GB8701022D0 (en)	1987-01-19	1987-02-18	Beecham Group Plc	Treatment
EP0340270B1 (en)	1987-11-14	1992-07-15	Beecham Group Plc	5-ht 3? receptor antagonists for treatment of cough and bronchoconstriction
EP0350130A3 (en)	1988-07-07	1991-07-10	Duphar International Research B.V	New substituted 1,7-annelated 1h-indazoles
US4895943A (en)	1988-10-25	1990-01-23	Pfizer Inc.	Preparation of 1,4-diazabicyclo(3.2.2)nonane
EP0377238A1 (en)	1988-12-22	1990-07-11	Duphar International Research B.V	New annelated indolo (3,2-c)-lactams
US5223625A (en)	1988-12-22	1993-06-29	Duphar International Research B.V.	Annelated indolo [3,2,-C]lactams
WO1990014347A1 (fr)	1989-05-24	1990-11-29	Nippon Shinyaku Co., Ltd.	Derives d'indole et medicament
US5446050A (en)	1989-11-17	1995-08-29	Pfizer Inc.	Azabicyclo amides and esters as 5-HT3 receptor antagonists
GB8928837D0 (en)	1989-12-21	1990-02-28	Beecham Group Plc	Pharmaceuticals
US5098889A (en)	1990-09-17	1992-03-24	E. R. Squibb & Sons, Inc.	Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
US5192770A (en)	1990-12-07	1993-03-09	Syntex (U.S.A.) Inc.	Serotonergic alpha-oxoacetamides
HU211081B (en)	1990-12-18	1995-10-30	Sandoz Ag	Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
WO1992012149A1 (en)	1991-01-09	1992-07-23	Smithkline Beecham Plc	Azabicydic and azatricydic derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
HU225047B1 (en) *	1991-03-28	2006-05-29	Eisai Co Ltd	Heterocyclic-piperidin-derivatives, pharmaceutical compositions containing them and process for their production
GB9121835D0 (en)	1991-10-15	1991-11-27	Smithkline Beecham Plc	Pharmaceuticals
US5273972A (en)	1992-03-26	1993-12-28	A. H. Robins Company, Incorporated	[(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
US5679673A (en)	1992-09-24	1997-10-21	The United States Of America, Represented By The Department Of Health And Human Services	Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
IT1256623B (it)	1992-12-04	1995-12-12	Federico Arcamone	Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
GB9406857D0 (en)	1994-04-07	1994-06-01	Sandoz Ltd	Improvements in or relating to organic compounds
SE9600683D0 (sv)	1996-02-23	1996-02-23	Astra Ab	Azabicyclic esters of carbamic acids useful in therapy
US5952363A (en) *	1997-03-04	1999-09-14	Novo Nordisk A/S	Pyrrolidine compounds useful in the treatment of diabetes
US6624173B1 (en)	1997-06-30	2003-09-23	Targacept, Inc.	Pharmaceutical compositions for treating and/or preventing CNS disorders
US6277870B1 (en)	1998-05-04	2001-08-21	Astra Ab	Use
US6953855B2 (en)	1998-12-11	2005-10-11	Targacept, Inc.	3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US7265115B2 (en) *	1999-01-29	2007-09-04	Abbott Laboratories	Diazabicyclic CNS active agents
ES2209825T3 (es) *	1999-01-29	2004-07-01	Abbott Laboratories	Derivados diazabiciclicos utiles como ligandos del receptor nicotinico de la acetilcolina.
FR2788982B1 (fr)	1999-02-02	2002-08-02	Synthelabo	Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
FR2791678B1 (fr)	1999-03-30	2001-05-04	Synthelabo	Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
CN100466134C (zh)	1999-07-12	2009-03-04	三菱电机株式会社	电磁接触器
SE9903760D0 (sv)	1999-10-18	1999-10-18	Astra Ab	New compounds
CA2399791A1 (en)	2000-02-11	2001-08-16	Bristol-Myers Squibb Company	Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
GB0010955D0 (en)	2000-05-05	2000-06-28	Novartis Ag	Organic compounds
CA2409644A1 (en)	2000-05-25	2001-11-29	Targacept, Inc.	Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
FR2809732B1 (fr)	2000-05-31	2002-07-19	Sanofi Synthelabo	DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
JP4616971B2 (ja)	2000-07-18	2011-01-19	田辺三菱製薬株式会社	１−アザビシクロアルカン化合物およびその医薬用途
US6492385B2 (en)	2000-08-18	2002-12-10	Pharmacia & Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6599916B2 (en)	2000-08-21	2003-07-29	Pharmacia & Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002017358A2 (en)	2000-08-21	2002-02-28	Pharmacia & Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
AU2002211176A1 (en)	2000-11-01	2002-05-15	Respiratorius Ab	Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3
US20020086871A1 (en) *	2000-12-29	2002-07-04	O'neill Brian Thomas	Pharmaceutical composition for the treatment of CNS and other disorders
EP1231212B1 (en)	2001-02-06	2006-12-20	Pfizer Products Inc.	Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders
PE20021019A1 (es)	2001-04-19	2002-11-13	Upjohn Co	Grupos azabiciclicos sustituidos
WO2002096911A1 (en) *	2001-06-01	2002-12-05	Neurosearch A/S	Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
JPWO2002100833A1 (ja)	2001-06-12	2004-09-24	住友製薬株式会社	Ｒｈｏキナーゼ阻害剤
AR036041A1 (es)	2001-06-12	2004-08-04	Upjohn Co	Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
AR036040A1 (es)	2001-06-12	2004-08-04	Upjohn Co	Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
DE60218493D1 (de)	2001-09-12	2007-04-12	Pharmacia & Upjohn Co Llc	Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
KR100614900B1 (ko)	2001-10-02	2006-08-25	파마시아 앤드 업존 캄파니 엘엘씨	질병의 치료를 위한 아자비시클릭-치환된 융합-헤테로아릴화합물
BR0213760A (pt)	2001-10-26	2004-10-19	Upjohn Co	Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
US6849620B2 (en)	2001-10-26	2005-02-01	Pfizer Inc	N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
EP1442037A1 (en)	2001-11-09	2004-08-04	PHARMACIA & UPJOHN COMPANY	Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
DE10156719A1 (de)	2001-11-19	2003-05-28	Bayer Ag	Heteroarylcarbonsäureamide
DE10162375A1 (de)	2001-12-19	2003-07-10	Bayer Ag	Bicyclische N-Aryl-amide
DE10305922A1 (de)	2002-06-10	2004-03-04	Bayer Ag	2-Heteroarylcarbonsäureamide
JP3985139B2 (ja)	2002-02-06	2007-10-03	日本ゼオン株式会社	変性重合体およびコーティング材
CA2476624A1 (en)	2002-02-19	2003-08-28	Pharmacia & Upjohn Company	Azabicyclic compounds for the treatment of disease
BR0307874A (pt)	2002-02-20	2004-12-28	Upjohn Co	Atividade de compostos azabicìclicos com receptor de acetilcolina nicotìnica alfa7
DE10211415A1 (de)	2002-03-15	2003-09-25	Bayer Ag	Bicyclische N-Biarylamide
ES2197001B1 (es)	2002-03-26	2004-11-16	Laboratorios Vita, S.A.	Procedimiento de obtencion de un compuesto farmaceuticamente activo.
WO2003094830A2 (en)	2002-05-07	2003-11-20	Neurosearch A/S	Novel azacyclic ethynyl derivatives
MXPA04011858A (es)	2002-05-30	2005-03-31	Neurosearch As	Quinuclidinas sustituidas en la posicion 3 y su uso.
CN1675204A (zh)	2002-06-10	2005-09-28	拜耳医药保健股份公司	2－杂芳基甲酰胺
GB0218625D0 (en)	2002-08-10	2002-09-18	Astex Technology Ltd	Pharmaceutical compounds
JP2006502133A (ja)	2002-08-10	2006-01-19	アステックス、セラピューティックス、リミテッド	サイクリン依存キナーゼ（ｃｄｋ）インヒビターとしての３−（カルボニル）１ｈ−インダゾール化合物
SE0202430D0 (sv)	2002-08-14	2002-08-14	Astrazeneca Ab	New Compounds
SE0202465D0 (sv)	2002-08-14	2002-08-14	Astrazeneca Ab	New compounds
US7456171B2 (en) *	2002-10-08	2008-11-25	Sanofi-Aventis	1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof
FR2845388B1 (fr)	2002-10-08	2004-11-12	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
US6945618B2 (en)	2003-06-02	2005-09-20	Accuride International Inc.	Drawer slide adjustment mechanism
TW200529860A (en) *	2003-12-22	2005-09-16	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
JP2005230084A (ja)	2004-02-17	2005-09-02	Olympus Corp	バルーン取付け治具
JP2007534692A (ja) *	2004-04-22	2007-11-29	メモリー・ファーマシューティカルズ・コーポレイション	インドール、１ｈ−インダゾール、１，２−ベンズイソキサゾール、１，２−ベンゾイソチアゾール、ならびにその調製および使用

2004
- 2004-12-22 JP JP2006545564A patent/JP4824578B2/ja not_active Expired - Fee Related
- 2004-12-22 NZ NZ548228A patent/NZ548228A/en not_active IP Right Cessation
- 2004-12-22 US US11/018,429 patent/US7396833B2/en not_active Expired - Fee Related
- 2004-12-22 SG SG200900253-6A patent/SG149830A1/en unknown
- 2004-12-22 AU AU2004309367A patent/AU2004309367B2/en not_active Ceased
- 2004-12-22 WO PCT/US2004/042852 patent/WO2005063767A2/en not_active Ceased
- 2004-12-22 RU RU2006126540/04A patent/RU2389729C2/ru not_active IP Right Cessation
- 2004-12-22 KR KR1020067012319A patent/KR20060120694A/ko not_active Ceased
- 2004-12-22 DK DK04814981T patent/DK1697378T3/da active
- 2004-12-22 PL PL04814981T patent/PL1697378T3/pl unknown
- 2004-12-22 EP EP04814981A patent/EP1697378B1/en not_active Expired - Lifetime
- 2004-12-22 BR BRPI0417323-6A patent/BRPI0417323A/pt not_active IP Right Cessation
- 2004-12-22 CA CA002550689A patent/CA2550689A1/en not_active Abandoned
- 2004-12-22 DE DE602004010299T patent/DE602004010299T2/de not_active Expired - Lifetime
- 2004-12-22 RS YUP-2006/0391A patent/RS20060391A/sr unknown
- 2004-12-22 ES ES04814981T patent/ES2295973T3/es not_active Expired - Lifetime
- 2004-12-22 PT PT04814981T patent/PT1697378E/pt unknown
2006
- 2006-06-13 IL IL176283A patent/IL176283A0/en unknown
- 2006-06-14 MA MA29103A patent/MA28228A1/fr unknown
- 2006-06-21 CR CR8472A patent/CR8472A/es not_active Application Discontinuation
- 2006-06-22 EC EC2006006669A patent/ECSP066669A/es unknown
- 2006-07-21 NO NO20063392A patent/NO20063392L/no not_active Application Discontinuation
2008
- 2008-05-29 US US12/128,839 patent/US7790722B2/en not_active Expired - Fee Related
2010
- 2010-08-17 US US12/857,617 patent/US7964600B2/en not_active Expired - Fee Related
2011
- 2011-06-17 US US13/162,786 patent/US8158629B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7964600B2 (en)	2011-06-21
US20110312989A1 (en)	2011-12-22
NZ548228A (en)	2009-04-30
RU2006126540A (ru)	2008-01-27
PL1697378T3 (pl)	2008-04-30
MA28228A1 (fr)	2006-10-02
AU2004309367B2 (en)	2010-04-01
KR20060120694A (ko)	2006-11-27
US8158629B2 (en)	2012-04-17
DK1697378T3 (da)	2008-03-17
US7790722B2 (en)	2010-09-07
US20110028483A1 (en)	2011-02-03
RS20060391A (sr)	2008-11-28
IL176283A0 (en)	2006-10-05
US20090088437A1 (en)	2009-04-02
EP1697378A2 (en)	2006-09-06
CR8472A (es)	2007-09-07
DE602004010299T2 (de)	2008-09-18
ECSP066669A (es)	2006-10-25
JP4824578B2 (ja)	2011-11-30
EP1697378B1 (en)	2007-11-21
CA2550689A1 (en)	2005-07-14
AU2004309367A1 (en)	2005-07-14
BRPI0417323A (pt)	2007-03-27
JP2007515424A (ja)	2007-06-14
PT1697378E (pt)	2008-02-28
US7396833B2 (en)	2008-07-08
DE602004010299D1 (de)	2008-01-03
SG149830A1 (en)	2009-02-27
US20050176754A1 (en)	2005-08-11
ES2295973T3 (es)	2008-04-16
WO2005063767A3 (en)	2005-08-25
WO2005063767A2 (en)	2005-07-14
RU2389729C2 (ru)	2010-05-20

Publication	Publication Date	Title
NO20063392L (no)	2006-09-21	Indoler, 1H-indazoler, 1,2-benzisoksazoler og 1,2-benzisotiazoler, og fremstilling og anvendelser derav
NO20051985L (no)	2005-06-09	Indazoler, benzotiazoler og benzoisotiazoler, samt fremstilling og anvendelser derav.
NO20064826L (no)	2006-12-20	Indazoler, benzotiazoler, benzoisotiazoler, benzisoksazoler og fremstilling og anvendelse derav
NO20065622L (no)	2007-02-02	H-indazoler, benzotiazoler, 1,2-benzoisoksazoler, 1,2-benzoisotiazoler og kromoner, og fremstilling og anvendelser derav.
DE602005024677D1 (de)	2010-12-23	Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
MX2007007328A (es)	2007-07-25	Ligandos del receptor alfa-7 nicotinico y preparacion y sus usos.
SG165417A1 (en)	2010-10-28	Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
DE602005019064D1 (de)	2010-03-11	Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
NO20064347L (no)	2006-09-26	Substituerte 1,2,3,4-tetrahydroisokinolinderivater
EA201001238A1 (ru)	2011-04-29	Соединения и композиции в качестве ингибиторов киназы
NO20064584L (no)	2006-10-10	Tetrahydropyridoindolderivater
NO20082092L (no)	2008-07-04	Pyrazolopyrimidiner som proteinkinaseinhibitorer
EA200800555A1 (ru)	2008-08-29	Производные ксантина в качестве селективных агонистов hm74a
EA200700501A1 (ru)	2007-08-31	Композиция (варианты) и способ для лечения гиперпролиферативных процессов, способ лечения рака (варианты) и способ получения твёрдой дисперсии вещества
NO20092138L (no)	2009-07-13	Forbindelser og sammensetninger som proteinkinase inhibitorer
NO20064771L (no)	2007-01-19	2-pyridyl substituerte imidazoler som ALK5 og/eller ALK4 inhibitorer
NO20072290L (no)	2007-05-30	Organiske forbindelser.
EA201070281A1 (ru)	2010-08-30	Производные индол-2-она, двузамещенные в положении 3, их получение и их применение в терапии
MY146403A (en)	2012-08-15	F, g, h, i and k crystal forms of imatinib mesylate
DOP2006000231A (es)	2007-05-31	Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
NO20053809L (no)	2005-10-17	Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
UA93348C2 (ru)	2011-02-10	Индазолы, бензотиазолы, бензоизотиазолы, их получение и применение
WO2007110709A3 (en)	2008-05-08	Formulations of tipifarnib for intravenous administration
DE602006008788D1 (de)	2009-10-08	Verbindungen
TNSN06190A1 (en)	2007-11-15	Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1, 2- benzisothiazoles, and preparation and uses thereof

Legal Events

Date	Code	Title	Description
2013-07-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application